Objective: Pharmacokinetics of FPA PVP coprecipitate was studied in order to provide reference for clinical use.
通过对诺氟沙星-聚维酮(FPA-PVP)共沉淀物在人体药物动力学考察,为临床用药提供理论参考。
Objective: Pharmacokinetics of FPA PVP coprecipitate was studied in order to provide reference for clinical use.
通过对诺氟沙星-聚维酮(FPA-PVP)共沉淀物在人体药物动力学考察,为临床用药提供理论参考。
Gatifloxacin eyedrops was prepared with benzalkonium as bacteriostat,NaCl as osmotic-pressure regulating agent and PVP as thickener:The content was determined with HPLC.
以苯扎溴铵为抑菌剂,氯化钠为渗透调节剂,聚乙烯吡咯烷酮(PVP)为增黏剂,制备加替沙星滴眼剂;采用高效液相色谱法测定含量。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Objective: Pharmacokinetics of FPA PVP coprecipitate was studied in order to provide reference for clinical use.
通过对诺氟沙星-维酮(FPA-PVP)共沉淀物在人体内药物动力学考察,
临床用药提供理论参考。
Gatifloxacin eyedrops was prepared with benzalkonium as bacteriostat,NaCl as osmotic-pressure regulating agent and PVP as thickener:The content was determined with HPLC.
以苯扎溴铵抑菌
,氯化
透
调
,
乙烯吡咯烷酮(PVP)
增黏
,制备加替沙星滴眼
;采用高效液相色谱法测定含量。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Objective: Pharmacokinetics of FPA PVP coprecipitate was studied in order to provide reference for clinical use.
通过对诺氟-聚维酮(FPA-PVP)共沉淀物在人体内药物动力学考察,为临床用药
论参考。
Gatifloxacin eyedrops was prepared with benzalkonium as bacteriostat,NaCl as osmotic-pressure regulating agent and PVP as thickener:The content was determined with HPLC.
以苯扎溴铵为抑菌剂,氯化钠为渗透调节剂,聚乙烯吡咯烷酮(PVP)为增黏剂,制备加替
眼剂;采用高效液相色谱法测定含量。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Objective: Pharmacokinetics of FPA PVP coprecipitate was studied in order to provide reference for clinical use.
通过对诺氟沙-聚维酮(FPA-PVP)共沉淀物在人体内
物动力学考察,为临床用
理论参考。
Gatifloxacin eyedrops was prepared with benzalkonium as bacteriostat,NaCl as osmotic-pressure regulating agent and PVP as thickener:The content was determined with HPLC.
以苯扎溴铵为抑菌剂,氯化钠为渗透调节剂,聚乙烯吡咯烷酮(PVP)为增黏剂,制备加替沙
剂;采用高效液相色谱法测定含量。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Objective: Pharmacokinetics of FPA PVP coprecipitate was studied in order to provide reference for clinical use.
通过对诺氟沙星-聚维酮(FPA-PVP)共沉淀物在人体内药物力学考察,为临床用药提供理论参考。
Gatifloxacin eyedrops was prepared with benzalkonium as bacteriostat,NaCl as osmotic-pressure regulating agent and PVP as thickener:The content was determined with HPLC.
以苯扎溴铵为抑菌剂,氯化钠为渗透调节剂,聚乙烯吡咯烷酮(PVP)为增黏剂,制备加替沙星滴眼剂;采用高效液相色谱法测定含量。
声明:以上句、词性分类均由互联网资源
成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Objective: Pharmacokinetics of FPA PVP coprecipitate was studied in order to provide reference for clinical use.
通过对诺氟沙星-聚维酮(FPA-PVP)共沉淀物在人体内药物动力学察,为临床用药提供理论参
。
Gatifloxacin eyedrops was prepared with benzalkonium as bacteriostat,NaCl as osmotic-pressure regulating agent and PVP as thickener:The content was determined with HPLC.
扎溴铵为抑菌
,氯化钠为渗透
调节
,聚乙烯吡咯烷酮(PVP)为增黏
,
加替沙星滴眼
;采用高效液相色谱法测定含量。
声明:上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Objective: Pharmacokinetics of FPA PVP coprecipitate was studied in order to provide reference for clinical use.
通过对诺氟沙星-聚维酮(FPA-PVP)共沉淀物内药物动力学考察,为临床用药提供理论参考。
Gatifloxacin eyedrops was prepared with benzalkonium as bacteriostat,NaCl as osmotic-pressure regulating agent and PVP as thickener:The content was determined with HPLC.
以苯扎溴铵为抑菌剂,氯化钠为渗透调节剂,聚乙烯吡咯烷酮(PVP)为增黏剂,制备加替沙星滴眼剂;采用高效液相色谱法测定
。
明:以上例句、词性分类均由互联网资源自动生成,部分未经过
工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Objective: Pharmacokinetics of FPA PVP coprecipitate was studied in order to provide reference for clinical use.
通过对诺氟沙星-聚维酮(FPA-PVP)共在人体内药
动力学考察,为临床用药提供理论参考。
Gatifloxacin eyedrops was prepared with benzalkonium as bacteriostat,NaCl as osmotic-pressure regulating agent and PVP as thickener:The content was determined with HPLC.
苯扎溴铵为抑菌剂,氯化钠为渗透
调节剂,聚乙烯吡咯烷酮(PVP)为增黏剂,制备加替沙星滴眼剂;采用高效液相色谱法测定含量。
声:
例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Objective: Pharmacokinetics of FPA PVP coprecipitate was studied in order to provide reference for clinical use.
通过对诺氟-聚维酮(FPA-PVP)共沉淀物在人体内药物动力学考察,为临床用药
论参考。
Gatifloxacin eyedrops was prepared with benzalkonium as bacteriostat,NaCl as osmotic-pressure regulating agent and PVP as thickener:The content was determined with HPLC.
以苯扎溴铵为抑菌剂,氯化钠为渗透调节剂,聚乙烯吡咯烷酮(PVP)为增黏剂,制备加替
眼剂;采用高效液相色谱法测定含量。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。